Get started
Author

Ramshanker Ramanathan

Observed names: R Ramanathan, Ramanathan, Ramshanker
Observed institutions: University of Southern Denmark, Odense University Hospital, Aarhus University Hospital, Kolding Hospital, Hospital South West Jutland, Lillebaelt Hospital
ORCID: 0000-0001-7794-9183
Observed ORCID: 0000-0001-7794-9183
OpenAlex ID: A5082824415
Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer
2010 · Erik D. Wiklund, Jesper B. Bramsen, et al. · International Journal of Cancer · 367
Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2009 · Lars Dyrskjøt, Marie S. Ostenfeld, et al. · Cancer Research · 363
NT-proBNP on Cobas h 232 in point-of-care testing: Performance in the primary health care versus in the hospital laboratory
2015 · Charlotte Gils, Ramshanker Ramanathan, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 17
Carotid plaque composition by CT angiography in asymptomatic subjects: a head-to-head comparison to ultrasound
2019 · Ramshanker Ramanathan, Damini Dey, et al. · European Radiology · 15
Sex difference in fibrin clot lysability: Association with coronary plaque composition
2018 · Ramshanker Ramanathan, Jørgen B. Gram, et al. · Thrombosis Research · 15
Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age
2013 · Ramshanker Ramanathan, Jørgen Gram, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 15
Sex difference in clot lysability and association to coronary artery calcification
2018 · Ramshanker Ramanathan, Niels Peter R. Sand, et al. · Biology of Sex Differences · 11
PDF
Factor VII-activating protease
2017 · Ramshanker Ramanathan, Jørgen B. Gram, et al. · Blood Coagulation & Fibrinolysis · 8
Factors associated with aortic valve calcification in type 2 diabetes—a Steno INTEN-CT substudy
2026 · Amal Haujir, Preman Kumarathurai, et al. · European Heart Journal - Cardiovascular Imaging · 1
[A peaceful Christmas Eve at the hospital].
2011 · Ramshanker Ramanathan, Mikkel Brabrand, et al. · PubMed · 1
Supplementary Table 4 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
PDF
Supplementary Figure 1 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
PDF
Supplementary Figure 3 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
PDF
Supplementary Table 3 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
PDF
Supplementary Table 5 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
Data from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
Supplementary Table 1 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
PDF
Supplementary Table 2 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
PDF
Supplementary Table 5 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
PDF
Data from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
Supplementary Figure 1 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
Supplementary Table 2 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
Supplementary Figure 3 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
Supplementary Figure 2 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
Supplementary Table 1 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
2023 · Lars Dyrskjøt, Marie S. Ostenfeld, et al.
Works count: 33
Citation count: 813
H-index: 8
I10-index: 7
Year
Topic
Type